Published in PLoS One on May 21, 2015
Twenty years of the MEROPS database of proteolytic enzymes, their substrates and inhibitors. Nucleic Acids Res (2015) 1.42
High-Throughput Multiplexed Peptide-Centric Profiling Illustrates Both Substrate Cleavage Redundancy and Specificity in the MMP Family. Chem Biol (2015) 0.83
Matrix- and plasma-derived peptides promote tissue-specific injury responses and wound healing in diabetic swine. J Transl Med (2016) 0.80
Correction: CleavPredict: A Platform for Reasoning about Matrix Metalloproteinases Proteolytic Events. PLoS One (2015) 0.76
Matrix Metalloproteinase (MMP) Proteolysis of the Extracellular Loop of Voltage-gated Sodium Channels and Potential Alterations in Pain Signaling. J Biol Chem (2015) 0.76
The Protein Data Bank. Nucleic Acids Res (2000) 187.10
Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers (1983) 99.69
Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol (2001) 66.87
WebLogo: a sequence logo generator. Genome Res (2004) 59.58
SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat Methods (2011) 33.90
New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer (2002) 24.71
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell (1996) 23.99
The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell (1997) 17.78
Matrix metalloproteinases: regulators of the tumor microenvironment. Cell (2010) 12.90
Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science (2002) 12.29
UniProt Knowledgebase: a hub of integrated protein data. Database (Oxford) (2011) 11.43
Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol (2007) 10.17
Thrombin signalling and protease-activated receptors. Nature (2000) 9.27
Caspases: intracellular signaling by proteolysis. Cell (1997) 7.46
MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell (1999) 6.40
Application of multiple sequence alignment profiles to improve protein secondary structure prediction. Proteins (2000) 6.22
The DISOPRED server for the prediction of protein disorder. Bioinformatics (2004) 5.98
Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat Rev Cancer (2006) 5.58
Matrix metalloproteinases: role in arthritis. Front Biosci (2006) 4.52
Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc Natl Acad Sci U S A (2000) 4.22
A series of PDB related databases for everyday needs. Nucleic Acids Res (2010) 3.60
Poxvirus pathogenesis. Microbiol Rev (1991) 3.54
Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev (2005) 3.30
MEROPS: the database of proteolytic enzymes, their substrates and inhibitors. Nucleic Acids Res (2013) 3.28
Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis (2005) 3.25
Proteome-derived, database-searchable peptide libraries for identifying protease cleavage sites. Nat Biotechnol (2008) 3.07
Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol (2001) 3.00
The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell (2001) 2.97
Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. Proc Natl Acad Sci U S A (1996) 2.93
Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor. Proc Natl Acad Sci U S A (2001) 2.82
Structure of the catalytic domain of the hepatitis C virus NS2-3 protease. Nature (2006) 2.58
CutDB: a proteolytic event database. Nucleic Acids Res (2006) 2.41
The presenilins in Alzheimer's disease--proteolysis holds the key. Science (1999) 2.32
Proteases: multifunctional enzymes in life and disease. J Biol Chem (2008) 2.30
Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates. Cardiovasc Res (2005) 2.15
The structural aspects of limited proteolysis of native proteins. Biochim Biophys Acta (1998) 2.14
The Swiss-Prot variant page and the ModSNP database: a resource for sequence and structure information on human protein variants. Hum Mutat (2004) 1.97
Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints. J Clin Invest (1997) 1.97
Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair? Nat Clin Pract Rheumatol (2008) 1.75
Proteases involved in cartilage matrix degradation in osteoarthritis. Biochim Biophys Acta (2011) 1.73
DbPTM 3.0: an informative resource for investigating substrate site specificity and functional association of protein post-translational modifications. Nucleic Acids Res (2012) 1.71
mentha: a resource for browsing integrated protein-interaction networks. Nat Methods (2013) 1.60
Matrix metalloproteinases as drug targets in infections caused by gram-negative bacteria and in septic shock. Clin Microbiol Rev (2009) 1.49
Multiplex N-terminome analysis of MMP-2 and MMP-9 substrate degradomes by iTRAQ-TAILS quantitative proteomics. Mol Cell Proteomics (2010) 1.48
Regulating S phase: CDKs, licensing and proteolysis. Cell (1996) 1.47
COXPRESdb: a database of comparative gene coexpression networks of eleven species for mammals. Nucleic Acids Res (2012) 1.46
Plakalbumin, alpha 1-antitrypsin, antithrombin and the mechanism of inflammatory thrombosis. Nature (1985) 1.44
Diminished corneal angiogenesis in gelatinase A-deficient mice. FEBS Lett (2001) 1.44
MMP-2 and MMP-9 synergize in promoting choroidal neovascularization. FASEB J (2003) 1.42
Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13. Arthritis Rheum (2002) 1.38
Suppression of atherosclerotic plaque progression and instability by tissue inhibitor of metalloproteinase-2: involvement of macrophage migration and apoptosis. Circulation (2006) 1.36
Updated biological roles for matrix metalloproteinases and new "intracellular" substrates revealed by degradomics. Biochemistry (2009) 1.34
Series "matrix metalloproteinases in lung health and disease": Matrix metalloproteinases in COPD. Eur Respir J (2011) 1.33
Metalloproteinases and vulnerable atherosclerotic plaques. Trends Cardiovasc Med (2007) 1.32
A scrutiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for the presence of MMPs synthesized by other cells. Bone (2004) 1.29
PROSPER: an integrated feature-based tool for predicting protease substrate cleavage sites. PLoS One (2012) 1.28
Mapping PDB chains to UniProtKB entries. Bioinformatics (2005) 1.26
Proteomic identification of multitasking proteins in unexpected locations complicates drug targeting. Nat Rev Drug Discov (2009) 1.21
Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation. Arthritis Rheum (2003) 1.18
The Wnt/planar cell polarity protein-tyrosine kinase-7 (PTK7) is a highly efficient proteolytic target of membrane type-1 matrix metalloproteinase: implications in cancer and embryogenesis. J Biol Chem (2010) 1.17
Matrix metalloproteinase proteolysis of the myelin basic protein isoforms is a source of immunogenic peptides in autoimmune multiple sclerosis. PLoS One (2009) 1.11
MMP9: a novel function in synaptic plasticity. Int J Biochem Cell Biol (2012) 1.06
AdTIMP-2 inhibits tumor growth, angiogenesis, and metastasis, and prolongs survival in mice. Hum Gene Ther (2001) 1.03
BAY 12-9566, a novel inhibitor of matrix metalloproteinases with antiangiogenic activity. Clin Cancer Res (1999) 0.99
Effect of broad-spectrum matrix metalloproteinase inhibition on atherosclerotic plaque stability. Cardiovasc Res (2006) 0.97
Structural determinants of limited proteolysis. J Proteome Res (2011) 0.95
Inflammatory proprotein convertase-matrix metalloproteinase proteolytic pathway in antigen-presenting cells as a step to autoimmune multiple sclerosis. J Biol Chem (2009) 0.95
On the size of the active site in proteases. I. Papain. 1967. Biochem Biophys Res Commun (2012) 0.92
A proteomic approach to identify substrates of matrix metalloproteinase-14 in human plasma. Biochim Biophys Acta (2004) 0.91
Transgenic TIMP-1 inhibits simian virus 40 T antigen-induced hepatocarcinogenesis by impairment of hepatocellular proliferation and tumor angiogenesis. Lab Invest (1999) 0.91
Basis for substrate recognition and distinction by matrix metalloproteinases. Proc Natl Acad Sci U S A (2014) 0.90
New details of HCV NS3/4A proteinase functionality revealed by a high-throughput cleavage assay. PLoS One (2012) 0.90
High-resolution analysis and functional mapping of cleavage sites and substrate proteins of furin in the human proteome. PLoS One (2013) 0.89
Substrate cleavage profiling suggests a distinct function of Bacteroides fragilis metalloproteinases (fragilysin and metalloproteinase II) at the microbiome-inflammation-cancer interface. J Biol Chem (2013) 0.88
High throughput substrate phage display for protease profiling. Methods Mol Biol (2009) 0.86
Internal cleavages of the autoinhibitory prodomain are required for membrane type 1 matrix metalloproteinase activation, although furin cleavage alone generates inactive proteinase. J Biol Chem (2010) 0.86
Bacterial toxins with intracellular protease activity. Clin Chim Acta (2000) 0.86
Cell cycle: the art of multi-tasking. Curr Biol (2010) 0.81
Smurf1 zaps the talin head. Nat Cell Biol (2009) 0.79
Sequence-derived structural features driving proteolytic processing. Proteomics (2013) 0.79
Matrix metalloproteinase proteolysis of the mycobacterial HSP65 protein as a potential source of immunogenic peptides in human tuberculosis. FEBS J (2011) 0.78